255 results on '"Weger R"'
Search Results
2. Clinical versus histological grading in the assessment of cutaneous graft versus host disease
3. Donor‐Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts
4. P09: ATTRITION RATES IN MULTIPLE MYELOMA UNDER REAL WORLD CONDITIONS – AN ANALYSIS FROM THE AUSTRIAN MYELOMA REGISTRY
5. Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value
6. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations
7. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations
8. Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations
9. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation
10. Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation
11. Congenital posterior pole cataract and adult onset dilating cardiomyopathy: expanding the phenotype of αB-crystallinopathies
12. H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts
13. Plasma Immunoglobulin Levels Prior to Cardiac Transplantation are Associated with Post-Transplantation Survival
14. CD4+FOXP3+ regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
15. T cells in Cardiac Allograft Vasculopathy Are Skewed to Memory Th-1 Cells in the Presence of a Distinct Th-2 Population
16. Health-related quality of life in multiple myeloma and mapping algorithms to derive health-state utility values: an overview
17. Clinical versus histological grading in the assessment of cutaneous graft versus host disease
18. Effectiveness of treatment sequences for elderly patients with multiple myeloma - a comparison of treatment schedules from clinical trials and experience from the Austrian Myeloma Registry
19. Clinical versus histological grading in the assessment of cutaneous graft versus host disease
20. Identification of human ccn2 * (connective tissue growth factor) promoter polymorphisms
21. Mapping Health-Related Quality of Life in Multiple Myeloma: Assessment of Existing Mapping Algorithms
22. PCN163 SEQUENTIAL TREATMENT REGIMENS FOR ELDERLY PATIENTS WITH MULTIPLE MYELOMA: A COST-EFFECTIVENESS ANALYSIS INCLUDING EXPERIENCE FROM REAL-WORLD DATA
23. PF649 ALPINA: REAL WORLD ANALYSIS OF 1ST LINE RVD TREATMENT IN TRANSPLANT ELIGIBLE AND TRANSPLANT-NON-ELIGIBLE MM PATIENTS WITH A FOCUS ON TOLERABILITY AND EFFICACY
24. Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma
25. P483The potential pathological role of cardiac autoantibodies in the development of heart failure
26. In Vivo Anti-MicroRNA Treatment in a Humanized Mouse Model for Allograft Vasculopathy
27. Liquid Biopsies: Non-Invasive Rejection Detection After Heart Transplantation
28. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer : A proof-of-concept study in the preoperative window period (ImPACCT)
29. Changes in Myocardial Microvascularisation After Heart Transplantation and During Cardiac Allograft Vasculopathy
30. Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts
31. Changes in Myocardial Microvascularisation After Heart Transplantation and During Cardiac Allograft Vasculopathy
32. In Vivo Anti-MicroRNA Treatment in a Humanized Mouse Model for Allograft Vasculopathy
33. Liquid Biopsies: Non-Invasive Rejection Detection After Heart Transplantation
34. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: A proof-of-concept study in the preoperative window period (ImPACCT)
35. Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts
36. Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses
37. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)
38. GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in theFmr1Knockout Mouse Model of Fragile X Syndrome
39. Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses
40. Identification of human ccn2 [*] (connective tissue growth factor) promoter polymorphisms
41. Overview on Epidemiological Data For Multiple Myeloma In Austria
42. Both Recipient and Donor Cells Are Involved in Human Cardiac Allograft Vasculopathy
43. The Amount of Autophagy-Related Cardiomyocyte Cell Death Is Associated With the Type of Pathogenic Mutation in Genetic Dilated Cardiomyopathy
44. Cytokine and MicroRNA Profiles of Ectopic Lymphoid Structures in Cardiac Allograft Vasculopathy
45. Both Recipient and Donor Cells Are Involved in Human Cardiac Allograft Vasculopathy
46. Cytokine and MicroRNA Profiles of Ectopic Lymphoid Structures in Cardiac Allograft Vasculopathy
47. The Amount of Autophagy-Related Cardiomyocyte Cell Death Is Associated With the Type of Pathogenic Mutation in Genetic Dilated Cardiomyopathy
48. Macrophages and antitumor reactions
49. Immune carriers of cytostatics
50. A survey of some formal models in tumor immunology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.